San Francisco, 2
November 2018: The insulindelivery devices market is
expected to reach USD 19.8 billion by 2025, according to a new report by Grand
View Research, Inc. The global industry is estimated to witness a high growth
during the forecast period from 2016 to 2025. Rapidly increasing number of
diabetics coupled with the escalating attention around diabetes care is a major
factor propelling the market.
Obesity, sedentary lifestyles, and
unhealthy food habits, primarily in the young population, lead to the
occurrence of diabetes. In addition, growing diabetic geriatric population is
another factor supporting the growth of this vertical. According to the United
Nations, Department of Economic and Social Affairs, around 901 million
individuals were aged 60 or over in 2015 and this number is projected to
increase to 1.4 billion by 2030. Thus, the enlarging elderly population is
expected to boost the demand for insulin delivery devices.
Technological innovations and advancements
are an ongoing trend in this vertical. Also, favorable reimbursement policies
for these devices, mainly in developed countries like the U.S. and Germany, are
anticipated to fuel the market growth during the study period. However,
stringent regulatory requirements regulating the approval of insulin delivery
devices is a major factor restraining the growth of this industry.
Access Research Report
of Insulin Delivery Devices Market @ www.grandviewresearch.com/industry-analysis/insulin-delivery-devices-market
Further Key Findings from the Study Suggest:
· The insulin pens segment was the largest
revenue-generating category of this market in 2015. The pen is equipped with
self-contained cartridges and offers ease in handling & less pain while
injecting insulin. Advantages of these pen devices over other products are
resulting in its growing popularity, thus serving as a vital factor in
contributing to the sector’s highest share in this market.
· Homecare is estimated to be the largest
shareholder and the fastest growing segment due to increased adoption of self-care
diabetes management devices and the availability of simplified and
user-friendly product designs for patients.
· North America is the leading regional
sector and accounted for the largest revenue share in 2015 primarily due to the
favorable reimbursement scenario in this space. Also, the presence of major
manufacturers in this region is supporting the market growth.
· The Asia Pacific region is anticipated to
be the fastest growing market during the forecast period. The high prevalence
rate of diabetes in the Asian countries, such as China and India, is a major
factor contributing to market expansion in this region.
· Some key players serving this vertical
include Novo Nordisk A/S; Sanofi; Eli Lilly and Company; Medtronic; Becton,
Dickinson and Company; Abbott; and F. Hoffmann-La Roche Ltd.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the
insulin delivery devices market on the basis of product, end-use, and region:
Insulin Delivery Devices Market Product
Outlook (Revenue, USD Million, 2014 - 2025)
·
Insulin syringes
·
Insulin pens
·
Insulin pumps
·
Insulin injectors
Insulin Delivery Devices End-use Outlook
(Revenue, USD Million, 2014 - 2025)
·
Hospitals
·
Home care
·
Others
Insulin Delivery Devices Market Regional
Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East and Africa
Access Press Release of
Insulin Delivery Devices Market@ www.grandviewresearch.com/press-release/global-insulin-delivery-devices-market-analysis
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment